🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Constellium stock faces pressure from lowered guidance, Deutsche Bank turns cautious

EditorEmilio Ghigini
Published 10/24/2024, 04:51 AM
CSTM
-

On Thursday, Deutsche Bank issued a downgrade for Constellium (NYSE:CSTM) from Buy to Hold, significantly reducing the stock's price target to $12 from the previous $22. This decision came after Constellium reported underwhelming third-quarter results, leading to a revised 2024 Adjusted EBITDA guidance of €580-600 million.

The company had previously paused its outlook during the second quarter and has now also retracted its 2025 EBITDA target of greater than €800 million due to a weakening demand outlook across most of its end-markets, with the exception of Packaging (NYSE:PKG).

The analyst at Deutsche Bank noted the downgrade and new price target, now based on a 5.0x 2025 estimated EBITDA multiple, down from 6.0x, is a reflection of the ongoing challenges Constellium is facing. These difficulties are anticipated to continue over the next few quarters until there is a potential improvement in demand across most of the company's end-markets, which could begin to materialize by mid next year.

The report also acknowledged the stock's significant sell-off on Thursday, which exceeded a 25% drop. The analyst suggested that this sharp decline might be viewed by some market participants as an opportunity to buy shares for those with a long-term investment horizon who already own the stock. Despite this perspective, the analyst's current stance remains cautious due to the present market conditions and company performance.

Constellium's financial performance and future outlook have clearly been affected by the current economic environment, leading to the withdrawal of its 2025 EBITDA target and adjusted guidance. The company is now navigating through these market challenges, which have been reflected in the stock's recent price movement and analyst expectations.

In other recent news, Constellium has reported mixed results for its third quarter of 2024. The company saw a decrease in shipments and revenue, with a significant drop in net income. Shipments fell by 5% year-over-year to 352,000 tons, while revenue decreased by 5% to EUR 1.6 billion. Net income was reported at EUR 3 million. Despite these challenges, Constellium remains committed to safety, cost management, and strategic growth.

The company's recent developments also include a share repurchase of 1.2 million shares for US $21 million in Q3. Furthermore, Constellium's new Recycling and Casting Center in Neuf-Brisach began operations ahead of schedule. The company's adjusted EBITDA for 2024 is projected between EUR 580 million and EUR 600 million, excluding specific impacts.

Challenges faced by the aerospace and automotive sectors were noted, with supply chain issues impacting production levels. However, the company remains optimistic about long-term market recovery and potential. The company's management is confident in their ability to navigate through market challenges and maintain operational performance.

InvestingPro Insights

Recent InvestingPro data paints a challenging picture for Constellium (NYSE:CSTM), aligning with Deutsche Bank's downgrade. The company's stock has experienced significant declines across multiple timeframes, with a 27.7% drop in the past week and a 46.32% fall over the last six months. These figures underscore the market's reaction to Constellium's recent performance and revised outlook.

Despite these headwinds, InvestingPro Tips highlight some potential positives. Management has been aggressively buying back shares, which could signal confidence in the company's long-term prospects. Additionally, the stock's current valuation implies a strong free cash flow yield, potentially offering value for patient investors.

For those considering Constellium's investment potential, it's worth noting that InvestingPro offers 13 additional tips for CSTM, providing a more comprehensive analysis of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.